The Canadian pet wellness market has grown steadily over the past decade. More pet owners are investing in high-quality supplements for their companion animals, and manufacturers around the world are taking notice. Entering this market is not as straightforward as adapting an existing product and shipping it north. Pet supplement regulations in Canada operate under a structured federal framework unlike any other in the world, and manufacturers who underestimate this complexity often face costly delays or enforcement action.
This guide covers what manufacturers need to know before bringing an animal health supplement to market in Canada.
What Is a Veterinary Health Product in Canada?
In Canada, most companion animal supplements are regulated as Veterinary Health Products (VHPs). These are defined as low-risk products in dosage form used to help maintain or improve the health and welfare of animals. They are not designed to diagnose, treat, prevent, or cure disease, and that distinction shapes everything from formulation to labelling.
VHPs are regulated under the Food and Drugs Act and typically contain ingredients such as vitamins, minerals, botanicals, probiotics, and traditional medicines with a history of safe use. Available dosage forms include tablets, capsules, chews, powders, liquids, pastes, and topical preparations.
How VHPs Differ from Veterinary Drugs
The line between a VHP and a veterinary drug comes down to the claims a product makes. A VHP supports general animal health without making therapeutic claims. The moment a product claims to treat, prevent, or cure a disease, it exits the VHP category entirely. It must follow the veterinary drug approval pathway, which carries significantly higher evidentiary and regulatory burdens. Getting this classification right at the development stage is one of the most important decisions a manufacturer will make.
Common Ingredients Permitted in VHPs
Ingredients used in VHPs must appear on Health Canada’s List of Permitted Substances. Common permitted ingredients include:
- Vitamins and minerals
- Herbal and botanical extracts
- Probiotics and prebiotics
- Amino acids and omega-3 fatty acids
- Homeopathic and traditional medicine substances
If an ingredient is absent from this list, manufacturers must submit a New Substance Application before including it in a notification.
The Regulatory Framework for Pet Supplements
Understanding the regulatory framework means knowing which federal body has authority over your product. Pet supplement regulations in Canada involve two distinct federal agencies, and the division of responsibility is not always obvious to manufacturers entering the Canadian market for the first time.
Health Canada’s Role
Health Canada’s pet products oversight applies specifically to VHPs. Since November 2017, Health Canada has administered the VHP Notification Program, which provides a flexible, risk-appropriate pathway for low-risk animal health supplements. Any manufacturer, importer, or seller of a VHP must notify Health Canada before placing the product on the market. Health Canada can stop the sale of any VHP found to be unsafe, misleading, or non-compliant, making post-market compliance an ongoing obligation.
The Canadian Food Inspection Agency (CFIA)
The CFIA administers certification and documentation requirements for pet food and animal-derived product imports, which directly affects VHP manufacturers whose formulations include fish oils, gelatin, or collagen. The CFIA’s Automated Import Reference System (AIRS) classifies supplements into three categories based on the presence and processing level of animal-origin ingredients. Manufacturers must ensure their import documentation aligns with the correct category to prevent border delays.
Step-by-Step Guide to Licensing Pet Supplements
Pet supplement licensing in Canada follows Health Canada’s VHP Notification Program. The process is more streamlined than a full drug approval, but it demands careful preparation and complete documentation throughout.
Step 1: Confirm Product Eligibility
Confirm that your product qualifies as a VHP. It must be a finished product in dosage form, contain only permitted ingredients, make no therapeutic claims, and use only approved routes of administration such as oral, topical, optic, nasal, or dental.
Step 2: Verify Ingredient Compliance
Every active and inactive ingredient must be listed on Health Canada’s List C: Veterinary Health Products. Any ingredient absent from this list requires a New Substance Application, which adds time and cost to the process.
Step 3: Prepare Your Notification Package
A complete VHP notification includes the product name and dosage form, a full ingredient list with quantities, the intended species and indications, quality documentation covering identity, purity, and potency, GMP compliance records, and a draft label.
Step 4: Submit to Health Canada
Manufacturers must notify Health Canada at least 30 calendar days before first selling or importing a VHP in Canada. A submission fee of $578 CAD applies per notification. Upon successful review, Health Canada issues a Notification Number (NN) that must appear prominently on the product label.
Step 5: Ensure Full Label Compliance
Every VHP label must carry the designation “Veterinary Health Product / Produit de santé animale,” the Notification Number, bilingual content in English and French, a full ingredient declaration, dosage instructions, and all required cautionary statements.
Step 6: Maintain Post-Market Obligations
Manufacturers must notify Health Canada at least 30 days before making any change to a notified VHP, including any updates to the formula, label, or manufacturer. Serious adverse reactions must be reported as required.
The Canadian Natural Health Product Registry helps manufacturers bring pet supplements to the Canadian market with confidence. Our team handles the full VHP notification process, from product classification and ingredient review to label compliance and submission. Contact us today.
Animal Health Products: Key Requirements
The submission must satisfy several non-negotiable standards. The table below summarises the core compliance requirements.
| Requirement | Detail | Timing |
| Notification Number (NN) | Issued by Health Canada upon successful review | Before the first sale or import |
| Ingredient Compliance | All ingredients on Health Canada’s List C | Before submission |
| GMP Compliance | The manufacturing site must follow Good Manufacturing Practices | Ongoing |
| Bilingual Labelling | English and French are required on all labels | Before submission |
| Notification Filing | Submit at least 30 days before the first sale or import | Pre-market |
| Change Notifications | Submit at least 30 days before any product changes | Ongoing |
| Adverse Reaction Reporting | Report serious adverse events to Health Canada | Post-market |
NHP for Pets: Why This Term Misleads Manufacturers
One area that frequently causes problems is the concept of NHP for pets. Some animal supplements contain ingredients also regulated as natural health products for humans, such as herbal extracts and probiotics. Manufacturers sometimes assume the human NHP framework applies to animal products. It does not.
In Canada, companion animal supplements are assessed under the VHP framework, not the human NHP pathway. Health Canada expects species-specific safety and quality documentation, meaning human NHP studies are generally not sufficient on their own. Manufacturers who overlook this distinction often submit incomplete applications and face significant notification delays.
Common Compliance Mistakes to Avoid
Entering the Canadian market without proper regulatory preparation is one of the most avoidable sources of business risk. The most frequent mistakes include:
- Assuming US or EU approval automatically qualifies a product for Canada
- Making therapeutic claims on VHP labels or marketing materials
- Using ingredients not listed on Health Canada’s permitted substances list
- Submitting notifications with incomplete quality documentation
- Missing the mandatory 30-day advance notification window before the first sale
Each of these errors can result in a product being stopped at the border, removed from sale, or subjected to enforcement action.
Frequently Asked Questions
What are the main Pet Supplement Regulations manufacturers must follow?
Pet Supplement Regulations fall under Health Canada’s VHP Notification Program, governed by the Food and Drugs Act. Manufacturers must notify Health Canada at least 30 days before selling or importing a VHP, use only permitted ingredients, comply with GMP standards, and maintain bilingual labels.
Do Health Canada pet products require pre-market approval?
It is classified as a VHP that goes through the Notification Program rather than full pre-market approval. Products cannot be sold or imported until the Notification Number is issued and all labelling and quality requirements are confirmed.
What does pet supplement licensing cost?
Pet supplement licensing through the VHP Notification Program requires a submission fee of $578 CAD for product notification. Additional costs may apply for quality testing, label reviews, and regulatory consulting, depending on the product’s complexity.
What qualifies as an Animal Health Product in Canada?
Its classification under the VHP program applies to low-risk products containing permitted ingredients such as vitamins, minerals, and botanicals, and making only general health maintenance claims for animals. Products making disease claims require the veterinary drug pathway instead.
Can a supplement approved as an NHP for pets in another country be sold in Canada?
No, NHP approvals for pet products from other jurisdictions are not recognized in Canada. Every product must go through Health Canada’s VHP Notification Program independently, supported by documentation meeting Canadian regulatory standards, including species-specific safety data.
Conclusion
Canada’s regulatory framework for animal health supplements is detailed, structured, and actively enforced. Manufacturers who understand pet supplement regulations in Canada well before formulation or label design move through the notification process far more efficiently than those who address compliance late.
The VHP Notification Program offers a practical pathway for low-risk products, but it demands accuracy, thorough documentation, and continued post-market diligence. Getting classification, ingredients, and labelling right gives manufacturers a real competitive advantage in one of Canada’s fastest-growing health product categories.
The Canadian Natural Health Product Registry provides end-to-end support for product licensing in the Canadian animal health supplement market. Our team brings decades of direct experience working with Health Canada, guiding manufacturers through every stage of the VHP notification process. Reach out to our team to get started!
Linda Beach is the founder, sole owner, and Director of Canadian Natural Health Product Registry (CNHPR), operating under Medical Botany Research. Based on Canada’s west coast, Linda has been providing regulatory consulting and compliance expertise to Canadian and international companies since 2004, when Canada’s Natural Health Products Regulations first came into effect.
A Certified Herbalist with a degree in Botany and Medical Research, Linda also holds certifications in several natural and complementary healing modalities. This combination of scientific training and hands-on herbal expertise gives her a unique perspective on the products she helps bring to market — from vitamins and herbal remedies to nutraceuticals, cosmeceuticals, and sports supplements.
Over her two decades working directly with Health Canada, Linda has built strong working relationships with regulators that have translated into consistent success in securing Natural Product Numbers (NPNs) for her clients. Her advocacy work has had industry-wide impact — including playing a key role in Health Canada’s decision to reinstate hempseed oil to its approved ingredient database after it had been removed, restoring a path to market for products containing the ingredient.
Through CNHPR, Linda guides clients through every stage of the licensing process: developing a tailored regulatory strategy, compiling required documentation, and managing submissions from signing through to Health Canada approval.
